Superpower Health

Tirzepatide Safety Information

Last Updated and Effective: 2.24.2026

Important Safety Information for Compounded Tirzepatide

WARNING: RISK OF THYROID C-CELL TUMORS

In animal studies, tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if tirzepatide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans. Tell your provider immediately if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

Do not use tirzepatide if:

  • You or any of your family have ever had medullary thyroid carcinoma (MTC).
  • You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is the use of Compounded Tirzepatide?

Compounded Tirzepatide is a GIP and GLP-1 receptor agonist. It is intended for use along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with:

  • Obesity (BMI $\ge 30 \text{ kg/m}^2$)
  • Overweight (BMI $\ge 27 \text{ kg/m}^2$) with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).

Limitations of Use:

  • It should not be used in combination with other tirzepatide-containing products or any other GLP-1 receptor agonist medications (e.g., semaglutide).
  • It has not been studied in patients with a history of pancreatitis.

Drug Interactions & History

Before using tirzepatide, it is critical to share your full medical history and a list of all medications, vitamins, and supplements.

Key Interactions to Watch For:

  • Hormonal Birth Control: Tirzepatide may decrease the efficacy of oral birth control pills. Switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting treatment and for 4 weeks after every dose increase.
  • Other GLP-1 Medications: Do not take with Wegovy, Ozempic, Mounjaro, or Saxenda.
  • Delayed Gastric Emptying: Tirzepatide slows stomach emptying, which may change how your body absorbs other oral medications.

Tell your provider if you have a history of:

  • Type 1 or Type 2 Diabetes
  • Pancreatitis
  • Kidney disease or Gastrointestinal disease
  • Diabetic retinopathy
  • Depression or suicidal thoughts

Serious Side Effects to Monitor

If you experience a medical emergency, call 911 immediately.

  • Pulmonary Aspiration During Anesthesia: Because tirzepatide slows stomach emptying, there is a risk of food/liquid entering the lungs during surgery under sedation. Inform your surgeon or anesthesiologist that you are taking tirzepatide well in advance of any planned procedure.
  • Severe Gastrointestinal Disease: May cause severe nausea, vomiting, or diarrhea.
  • Acute Gallbladder Disease: Watch for upper stomach pain, fever, or yellowing of the skin (jaundice).
  • Acute Kidney Injury: Dehydration from GI side effects can cause kidney stress. Drink plenty of water.
  • Severe Allergic Reactions: Seek help for swelling of the face/tongue, breathing problems, or severe rash.
  • Suicidal Behavior: Monitor for sudden changes in mood, thoughts, or feelings.

Common Side Effects

  • Nausea and Vomiting
  • Diarrhea or Constipation
  • Stomach pain and Indigestion
  • Injection site reactions
  • Feeling tired (Fatigue)
  • Hair loss
  • Belching or Heartburn

Note on Pregnancy: Tirzepatide should not be used during pregnancy as weight loss offers no benefit to the fetus and may cause harm. If you are a female of reproductive potential, use effective non-oral contraception. If you become pregnant, discontinue use immediately.

To report negative side effects, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

‍